Correspondence |

Major Abdominal Surgery With Continued Dual Antiplatelet Therapy

Markus Quante, MD; Christoph Benckert, MD; Armin Thelen, MD; Udo Kaisers, MD; Sven Jonas, MD
Arch Surg. 2011;146(11):1334-1336. doi:10.1001/archsurg.2011.300.
Text Size: A A A
Published online


To our knowledge, large prospective studies with a high degree of evidence on antiplatelet regimens during noncardiac surgery are lacking. Recently, Chernoguz et al1 reported a significantly increased risk of postoperative bleeding in patients who received clopidogrel bisulfate before major abdominal surgery. An invited comment2 on their study1 pointed out that cessation of antiplatelet therapy can result in an increased risk of major adverse cardiac events due to stent thrombosis (eg, myocardial infarction and its possible fatal outcome). Current guidelines3 recommend that elective, noncardiac surgery be postponed for at least 6 weeks after the placement of bare-metal stents and for at least 1 year after the placement of drug-eluting stents. The question remains whether to continue or discontinue antiplatelet therapy and face the risk of either perioperative bleeding or adverse cardiac events, especially in urgent situations. With this question in mind, and in contrast to the study by Chernoguz et al,1 we report a small case series of 7 consecutive patients who underwent major abdominal surgery while receiving dual antiplatelet therapy in our hospital between October 2009 and July 2010.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





November 1, 2011
Artur Chernoguz, MD; Celia M. Divino, MD
Arch Surg. 2011;146(11):1334-1336. doi:10.1001/archsurg.2011.301.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles

Users' Guides to the Medical Literature
Example 3